Dapagliflozin Pharmacokinetics Is Similar in Adults with Type 1 and Type 2 Diabetes Mellitus.
Sign Up to like & getrecommendations! Published in 2022 at "Journal of clinical pharmacology"
DOI: 10.1002/jcph.2062
Abstract: Dapagliflozin improves glycemic control in patients with type 2 diabetes mellitus (T2DM) and is approved in Japanese patients with type 1 diabetes mellitus (T1DM) with inadequate glycemic control. The objectives of this work were to… read more here.
Keywords: patients t1dm; dapagliflozin systemic; dapagliflozin pharmacokinetics; type diabetes ... See more keywords
Subclinical Atherosclerosis in Patients With Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis
Sign Up to like & getrecommendations! Published in 2019 at "Angiology"
DOI: 10.1177/0003319718787366
Abstract: Cardiovascular (CV) risk in type 1 diabetes mellitus (T1DM) is increased. In this study, we evaluated the differences in major markers of CV risk between patients with T1DM and healthy controls by a systematic review… read more here.
Keywords: review meta; systematic review; patients t1dm; type diabetes ... See more keywords
Metabolic syndrome associated with higher glycemic variability in type 1 diabetes: A multicenter cross-sectional study in china
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Endocrinology"
DOI: 10.3389/fendo.2022.972785
Abstract: Aims The comorbidity of metabolic syndrome (MetS) and type 1 diabetes mellitus (T1DM) is an obstacle to glucose control in patients with T1DM. We compared glycemic profiles using continuous glucose monitoring (CGM) systems in patients… read more here.
Keywords: patients t1dm; multicenter cross; metabolic syndrome; cross sectional ... See more keywords